CONMED (NYSE: CNMD) director gets 5,772 RSUs, converts 668 units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CONMED Corp director LaVerne H. Council reported compensation-related equity activity. On June 2, 2026, Council exercised 668 RSUs into the same number of common shares, bringing direct common stock holdings to 4,716 shares after the transaction. There were no open-market purchases or sales.
On June 1, 2026, Council received a grant of 5,772 RSUs under CONMED’s 2025 Long-Term Incentive Plan. Each RSU represents a contingent right to receive one share of common stock and is generally scheduled to vest 100% after one year, aligning the director’s compensation with future company performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
668 shares exercised/converted
Mixed
3 txns
Insider
Council LaVerne H
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | RSUs (Restricted Stock Units) | 668 | $0.00 | -- |
| Exercise | Common Stock | 668 | $0.00 | -- |
| Grant/Award | RSUs (Restricted Stock Units) | 5,772 | $0.00 | -- |
Holdings After Transaction:
RSUs (Restricted Stock Units) — 0 shares (Direct, null);
Common Stock — 4,716 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
Key Figures
RSUs granted: 5,772 units
RSUs exercised: 668 units
Common shares held: 4,716 shares
+1 more
4 metrics
RSUs granted
5,772 units
RSU grant on June 1, 2026 under 2025 Long-Term Incentive Plan
RSUs exercised
668 units
RSUs converted to common stock on June 2, 2026
Common shares held
4,716 shares
Direct common stock ownership after June 2, 2026 transaction
RSU vesting schedule
100% after one year
RSUs under 2025 Long-Term Incentive Plan generally vesting
Key Terms
RSUs (Restricted Stock Units), 2025 Long-Term Incentive Plan, grant, award, or other acquisition, Exercise or conversion of derivative security
4 terms
RSUs (Restricted Stock Units) financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
2025 Long-Term Incentive Plan financial
"subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
FAQ
What insider transactions did CONMED (CNMD) director LaVerne H. Council report?
LaVerne H. Council reported exercising 668 restricted stock units into common stock and receiving a new grant of 5,772 RSUs. These are equity compensation events, not open-market stock purchases or sales.
What are the details of LaVerne H. Council’s new RSU grant at CONMED (CNMD)?
On June 1, 2026, Council received 5,772 restricted stock units, each representing a right to one CONMED common share. The RSUs are granted under the 2025 Long-Term Incentive Plan and are generally scheduled to vest 100% after one year.
Did LaVerne H. Council buy or sell CONMED (CNMD) stock on the open market?
The Form 4 does not show any open-market purchases or sales. It reports an RSU exercise converting 668 units into common shares and a 5,772-unit RSU grant, both categorized as compensation-related equity transactions.
How do the reported RSU transactions affect CONMED (CNMD) director alignment?
The 5,772-unit RSU grant and 668-unit RSU exercise increase Council’s equity-based compensation. Because the RSUs generally vest 100% after one year, they are designed to align the director’s incentives with CONMED’s future share performance.